RadNet, Inc. (RDNT) stock
RDNTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/3058% above fair value
$74.92−1.97 (-2.56%)
Close on Nov 17, 2026Market cap $5.90BP/E –Yield –
RadNet pe ratio
The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.
RadNet's pe ratio was 464.6× on Oct 31, 2024, against 162.7× a year earlier. Over the last 5 years it ranged from 16.8× to 973.2×, with a median of 62.4×.
PE Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2024 | Oct 31, 2024 | 464.6× | −129.8 |
| 2023 | Dec 29, 2023 | 594.4× | +455.4 |
| 2022 | Dec 30, 2022 | 139.0× | +92.6 |
| 2021 | Dec 31, 2021 | 46.3× | −350.9 |
| 2020 | Jul 31, 2020 | 397.3× | +367.0 |
| 2019 | Dec 31, 2019 | 30.3× | −13.8 |
| 2018 | Jan 31, 2018 | 44.1× | +0.2 |
| 2017 | Dec 29, 2017 | 43.9× | −20.6 |
| 2016 | Dec 30, 2016 | 64.5× | +39.8 |
| 2015 | Dec 31, 2015 | 24.7× | −74.7 |
| 2014 | Apr 30, 2014 | 99.4× | +98.2 |
| 2013 | Dec 31, 2013 | 1.2× | −6.8 |
| 2012 | Dec 31, 2012 | 7.9× | +5.4 |
| 2011 | Dec 30, 2011 | 2.5× | – |
See a number that looks wrong?